Using analysis of DNA methylation data from UALCAN, we verified that the TNK2 promoter methylation level was reduced in colon cancer compared with that in normal tissues (Figure 4G), which was the opposite of TNK2 expression. The gene discussed is TNK2; the disease is malignant colon neoplasm.